Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

    Forecasted

    This grant funds research to develop and test precision drug-radiation combination therapies that exploit tumor-specific vulnerabilities, aiming to improve cancer treatment outcomes.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

    This grant funds projects to further develop and validate innovative technologies that advance cancer research or clinical care, focusing on technical improvements and rigorous validation for broad adoption.

    HHS-NIH11Forecasted Jun 4, 2027$300,000Forecasted

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development for improving analysis and handling of biospecimens in basic or clinical cancer research, focusing on proof-of-concept studies.

    HHS-NIH11Due Nov 10, 2026· 15d$150,000

    Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required)

    This grant funds a national research network to study how cancer and normal tissues respond biologically to radiation therapy, aiming to improve treatment and discover new therapy opportunities.

    HHS-NIH11Forecasted Jan 25, 2027Forecasted

    Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)

    This grant funds research centers to conduct innovative, translational studies aimed at improving prevention, detection, diagnosis, and treatment of specific or related human cancers, requiring clinical trials.

    HHS-NIH11Due Sep 25, 2029$1,400,000

    Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

    This grant funds early-stage, highly innovative technology development projects to improve cancer research or clinical care, focusing on proof-of-concept studies with high potential impact in cancer-related fields.

    HHS-NIH11Forecasted Jun 4, 2027$150,000Forecasted